A viable alternative to classical media supplemented with 10% FBS is reduced-serum media formulations. These formulations of classical media types, such as DMEM and RPMI, are nutritionally enhanced using the natural components of serum, including lipids, growth factors and proteins, which allow the use of serum to be reduced as low as 2% depending on cell type. Additionally, the reduced serum content in a user’s media helps to reduce any variability in their cell culture due to variability in serum batches, enabling a more flexible process.
The HyClone range of reduced-serum media, along with the full HyClone portfolio of media, serum, buffers and process supplements, is distributed in Australia by In Vitro Technologies. The company provides full product support for the range including serum batch testing support and media customisation.
Phone: 03 9771 3700
Cytek Tonbo Reagents
Cytek Tonbo Reagents are designed to enable high-quality research without breaking the budget....
Selleck Chemicals FDA-approved Anticancer Drug Library
Selleck Chemicals (SelleckChem) offers a collection of 1734 approved drugs with potential...
Cytek Tonbo Mouse TBNK/Myeloid/Treg Kit
The kit has been designed to enable researchers to quickly perform basic immunophenotyping and...
